Migraine Trial, Recruiting (NCT07267819)

Migraine Trial, Recruiting NCT07267819 Sponsor: Uniformed Services University of the Health Sciences Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT07267819 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be at least 18 years old
You must be able to read and sign a consent form written in English
You must be a US Government employee, or an adult family member of a US Government employee
You must have already received Xeomin injections (a type of botulinum toxin treatment) to help prevent migraines connected to a traumatic brain injury or acute head injury, at a military or other US medical facility
You must be able to attend and complete at least 80% of the study check-ins or assessments
You must be a US citizen only, and not hold citizenship in another country where you are currently living

Who may not be able to join:

You cannot join if you are currently a prisoner
You cannot join if you are not able to make your own medical decisions or give informed consent
You cannot join if you are not a US citizen

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 314-537-6453

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07267819

Sponsor: Uniformed Services University of the Health Sciences

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: 314-537-6453

More information: https://clinicaltrials.gov/study/NCT07267819

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be at least 18 years old
You must be able to read and sign a consent form written in English
You must be a US Government employee, or an adult family member of a US Government employee
You must have already received Xeomin injections (a type of botulinum toxin treatment) to help prevent migraines connected to a traumatic brain injury or acute head injury, at a military or other US medical facility
You must be able to attend and complete at least 80% of the study check-ins or assessments
You must be a US citizen only, and not hold citizenship in another country where you are currently living

Who may not be able to join:

You cannot join if you are currently a prisoner
You cannot join if you are not able to make your own medical decisions or give informed consent
You cannot join if you are not a US citizen

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Uniformed Services University of the Health Sciences

Registry

ClinicalTrials.gov

Start date

5 August 2025

Est. completion

6 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent Change in Migraine Headache Intensity from Baseline to Peak Effect (4 weeks post-treatment) and to wearing off (12 weeks post-treatment).; Percent Change in Migraine Headache Frequency from Baseline to Peak Effect (4 weeks post-treatment) and to wearing off (12 weeks post-treatment).; Percent Change in Headache Impact Test (HIT-6) Score from Baseline to Peak Effect (4 weeks post-treatment) and to wearing off (12 weeks post-treatment).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov